{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:29:35Z","timestamp":1772148575638,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Infectious Diseases"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1016\/s1473-3099(01)00063-9","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T06:45:57Z","timestamp":1027579557000},"page":"85-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance"],"prefix":"10.1016","volume":"1","author":[{"given":"Keith P","family":"Klugman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S1473-3099(01)00063-9_bib1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.13.2.302","article-title":"Worldwide Haemophilus influenzae disease at the beginning of the 21st century: global analysis of the disease burden after the use of the polysaccharide vaccine and a decade after the advent of conjugates","volume":"13","author":"Peltola","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/S1473-3099(01)00063-9_bib2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00006454-199504000-00008","article-title":"Anticapsular polysaccharide antibody concentrations in saliva after immunisation with Haemophilus influenzae type b conjugate vaccines","volume":"14","author":"Kauppi","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/S1473-3099(01)00063-9_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00006454-200101000-00006","article-title":"Serum and salivary anti-capsular antibodies in infants and children immunised with the heptavalent pneumococcal conjugate vaccine","volume":"20","author":"Nurkka","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/S1473-3099(01)00063-9_bib4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1086\/319246","article-title":"Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin A, pneumolysin, and pneumococcal surface protein A in children","volume":"183","author":"Simell","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/S1473-3099(01)00063-9_bib5","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1086\/315822","article-title":"Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media","volume":"182","author":"Rapola","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/S1473-3099(01)00063-9_bib6","doi-asserted-by":"crossref","unstructured":"Barbour ML, Mayon-White RT, Coles C, Crook DWM, Moxon ER. The effect of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis; 171: 93\u201398","DOI":"10.1093\/infdis\/171.1.93"},{"key":"10.1016\/S1473-3099(01)00063-9_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(05)65585-7","article-title":"Carriage of pneumococci after pneumococcal vaccination","volume":"348","author":"Obaro","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/S1473-3099(01)00063-9_bib8","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/infdis\/174.6.1271","article-title":"Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine","volume":"174","author":"Dagan","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/S1473-3099(01)00063-9_bib9","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/315009","article-title":"Immunogenicity and effect on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine","volume":"180","author":"Mbelle","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/S1473-3099(01)00063-9_bib10","unstructured":"Dagan R, Givon N, Yagupsky P, et al. Effect of a nine-valent pneumococcal vaccine conjugated to CRM197 (PncCRM9) on nasopharyngeal (NP) carriage of vaccine type and non-vaccine type S. Pneumoniae (Pnc) strains among day care center (DCC) attendees. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 1998; San Diego, California: p 299 (abstr G-52)"},{"key":"10.1016\/S1473-3099(01)00063-9_bib11","doi-asserted-by":"crossref","unstructured":"Dagan R, Fraser D, Givon N, Yagupsky P. Carriage of resistant pneumococci by children in southern Israel and effect of conjugate vaccines on carriage. Clin Microbiol Infect; 5: 4S29\u20134S37","DOI":"10.1111\/j.1469-0691.1999.tb00854.x"},{"key":"10.1016\/S1473-3099(01)00063-9_bib12","unstructured":"Lakshman R, Race G, Shaw L, Murdoch C, Pettitt E, Finn A. Effect of heptavalent conjugate pneumococcal vaccine in infancy and booster polysaccharide vaccine at 13 months on nasopharyngeal carriage of S pneumoniae in children aged 2\u20134 years. 19th Annual Meeting of the European Society for Paediatric Infectious Diseases; March 2001; Istanbul, Turkey: p 21 (abstr)"},{"key":"10.1016\/S1473-3099(01)00063-9_bib13","unstructured":"O'Brien KL, Bronsdon MA, Carlone GM, et al. Effect of a 7-valent pneumococcal conjugate vaccine on nasopharyngeal (NP) carriage among Navajo and White Mountain Apache (N\/WMA) infants. Society for Pediatric Research; April 2001; Baltimore, MD, USA. (abstr 1463)"},{"key":"10.1016\/S1473-3099(01)00063-9_bib14","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/S0264-410X(00)00046-3","article-title":"Competition among Streptococcus pneumoniae for intranasal colonisation in a mouse model","volume":"18","author":"Lipsitch","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/S1473-3099(01)00063-9_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/infdis\/173.1.136","article-title":"Antibody-secreting cells and their relation to humoral antibodies in serum and in nasopharyngeal aspirates in children with pneumococcal acute otitis media","volume":"173","author":"Nieminen","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/S1473-3099(01)00063-9_bib16","unstructured":"Kilpi TM, Syrj\u00e4nen R, Palmu A, et al. Parallel evaluation of the effect of a 7-valent pneumococcal conjugate vaccine (PNCCRM) on pneumococcal (PNC) carriage and acute otitis media (AOM). 19th Annual Meeting of the European Society for Paediatric Infectious Diseases; March, 2001; Istanbul: p 4 (abstr)"},{"key":"10.1016\/S1473-3099(01)00063-9_bib17","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/00006454-199711000-00011","article-title":"Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunisation with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid","volume":"16","author":"Dagan","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/S1473-3099(01)00063-9_bib18","unstructured":"Kristinsson KG, Sigurdardottir ST, Gudnason T, Kjartansson S, Davidsdottir K, Leroy O. Effect of vaccination with octavalent protein conjugated pneumococcal vaccines on pneumococcal carriage in infants. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 1997; Toronto, Canada: p 193 (abstr G-5)"},{"key":"10.1016\/S1473-3099(01)00063-9_bib19","unstructured":"Dagan R, Zamir O, Tirosh N, et al. Nasopharyngeal (NP) carriage of Streptococcus pneumoniae (Pnc) in toddlers vaccinated during infancy with an 11-valent pneumococcal vaccine conjugated to diphtheria and tetanus toxoids (PCV-DT). 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 2000; Toronto, Canada: p 236 (abstr 47)"},{"key":"10.1016\/S1473-3099(01)00063-9_bib20","unstructured":"Dagan R, Givon-Lavi M, Porat M, Sikuler-Cohen M, Fraser D. Immunisation of toddlers attending day care centers (DCCs) with a nine-valent conjugate pneumococcal vaccine (PncCRM9) reduces transmission of Streptococcus pneumoniae (Pnc) and antibiotic-resistant S. pneumoniae (R-Pnc) to their young siblings (YS). 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 2000; Toronto, Canada: p 244 (abstr 687)"},{"key":"10.1016\/S1473-3099(01)00063-9_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/S1473-3099(01)00063-9_bib22","unstructured":"O'Brien KL, Moulton L, Reid R, et al. Invasive disease efficacy of a 7-valent pneumococcal conjugate vaccine among Navajo and White Mountain apache (N\/WMA) children. Society for Pediatric Research; April 2001; Baltimore, MD, USA (abstr 1371)"},{"key":"10.1016\/S1473-3099(01)00063-9_bib23","unstructured":"Black S, Shinefield H, Ray P, et al. Efficacy of heptavalent pneumococcal conjugate pneumococcal vaccine (Wyeth Lederle) in 37 000 infants and children: effect on pneumonia, otitis media, and an update on invasive disease. 2nd International Symposium on Pneumococci and Pneumococcal Diseases, March 2000, Sun City, South Africa (abstr O19)"},{"key":"10.1016\/S1473-3099(01)00063-9_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S1473-3099(01)00063-9_bib25","unstructured":"Kilpi T, Palmu A, Leinonen M, Eskola J, Finom SG. Efficacy of a seven-valent pneumococcal conjugate vaccine (PncOMPC) against serotype-specific otitis media (AOM) caused by streptococcus pneumoniae (PNC). 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 2000; Toronto, Canada: p 245 (abstr 689)"},{"key":"10.1016\/S1473-3099(01)00063-9_bib26","unstructured":"Palmu AAI, Kilpi TM, Jokinen J, Makela PH, The Fin OM Study Group. Further characterization of efficacy of a heptavalent pneumococcal conjugate vaccine (PNCCRM) against acute otitis media. 19th Annual Meeting of the European Society for Paediatric Infectious Diseases; March 2001; Istanbul: p 22 (abstr)"},{"key":"10.1016\/S1473-3099(01)00063-9_bib27","unstructured":"Fireman B, Shinefield H, Black S, Lewis E, Lee J. Effectiveness of pneumococcal conjugate vaccine for the prevention of acute otitis media, by age and season. 19th Annual Meeting of the European Society for Paediatric Infectious Diseases; March 2001; Istanbul, Turkey: p 5 (abstr)"},{"key":"10.1016\/S1473-3099(01)00063-9_bib28","unstructured":"Dagan R, Sikuler-Cohen M, Givon-Lavi N, et al. A 9-valent pneumococcal CRM197 vaccine (PncCRM9) has a major effect on morbidity and antibiotic (AB) use in day care centers (DCCs). Pediatric Academic Societies and American Academy of Pediatrics Joint Meeting; May 2000; Boston, MA, USA: p260A (abstr 1530)"},{"key":"10.1016\/S1473-3099(01)00063-9_bib29","unstructured":"Dagan R, Fraser D, Janco J, et al. Reduction of antibiotic-resistant pneumococcal (Pnc) nasopharyngeal colonisation (NP-col) in toddlers attending day care centers (DCCs) after vaccination with a 9-valent CRM197 conjugate pneumococcal vaccine (PncCRM9). 18th Meeting of the European Society for Pediatric Infectious Diseases; May 2000; Noordwijk, Netherlands: p19 (abstr O-12)"},{"key":"10.1016\/S1473-3099(01)00063-9_bib30","unstructured":"Shinefield HR, Black SS, Lewis EM, Hackell J, Malinoski F. Efficacy of seven-valent pneumococcal conjugate vaccine in premature and low birthweight infants. 19th Annual Meeting of the European Society for Paediatric Infectious Diseases; March 2001; Istanbul, Turkey: p 3 (abstr)"},{"key":"10.1016\/S1473-3099(01)00063-9_bib31","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.283.11.1460","article-title":"Projected cost-effectiveness of pneumococcal vaccination of healthy infants and young children","volume":"283","author":"Lieu","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/S1473-3099(01)00063-9_bib32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00006454-200003000-00002","article-title":"Pneumococcal conjugate vaccine vaccination for adults: why it's important for children","volume":"19","author":"Fedson","year":"2000","journal-title":"Pediatr Infect Dis J"}],"container-title":["The Lancet Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473309901000639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473309901000639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:55:25Z","timestamp":1761468925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473309901000639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["S1473309901000639"],"URL":"https:\/\/doi.org\/10.1016\/s1473-3099(01)00063-9","relation":{},"ISSN":["1473-3099"],"issn-type":[{"value":"1473-3099","type":"print"}],"subject":[],"published":{"date-parts":[[2001,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance","name":"articletitle","label":"Article Title"},{"value":"The Lancet Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1473-3099(01)00063-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}